CASP1 and preeclampsia: Liu et al. suggested that LXA4 suppresses AT1-AA production by modulating caspase-1 as well as enhancing phagocytosis of apoptotic trophoblast cells by macrophages, supporting caspase-1 serving as a therapeutic target for attenuating AT1-AA and LXA4 to protect patients from preeclampsia [64].